Literature DB >> 10920181

Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group.

C Chase1, J Ware, J Hittelman, I Blasini, R Smith, A Llorente, E Anisfeld, C Diaz, M G Fowler, J Moye, L I Kaligh.   

Abstract

OBJECTIVE: To examine the frequency, timing, and factors associated with abnormal cognitive and motor development during the first 30 months of life in infants born to women infected with human immunodeficiency virus type 1 (HIV-1).
METHODS: Serial neurodevelopmental assessment was performed with 595 infants born to women infected with HIV-1 in a multicenter, prospective, natural history cohort study. Survival analysis methods were used to evaluate 6 outcome events related to abnormal cognitive and motor growth (time to confirmed drop of 1 SD, time to first score <69, and time to confirmed drop of 2 SD) in Bayley Scales of Infant Development Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI) scores among infected (n = 114) and uninfected (n = 481) infants. Proportional hazards modeling was used to evaluate the effects of HIV infection status, prematurity, prenatal exposure to illicit drugs, maternal educational attainment, and primary language.
RESULTS: HIV-1 infection was significantly associated with increased risk for all outcome events related to abnormal mental and motor growth. Differences between infected and uninfected infants were apparent by 4 months of age. Prematurity was associated with increased risk for MDI <69 and PDI <69. Maternal education of <9 completed years was associated with increased risk for MDI <69. Neither prenatal exposure to illicit drugs nor primary language other than English was associated with abnormal development.
CONCLUSION: A significant proportion of infants with HIV-1 infection show early and marked cognitive and motor delays or declines that may be important early indicators of HIV disease progression. These abnormalities are independent of other risk factors for developmental delay.

Entities:  

Mesh:

Year:  2000        PMID: 10920181     DOI: 10.1542/peds.106.2.e25

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children.

Authors:  Sarah F Benki-Nugent; Ira Martopullo; Tony Laboso; Nancy Tamasha; Dalton C Wamalwa; Kenneth Tapia; Agnes Langat; Elizabeth Maleche-Obimbo; Christina M Marra; Paul Bangirana; Michael J Boivin; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2019-05-01       Impact factor: 3.731

3.  Correlates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy.

Authors:  Sarah Benki-Nugent; Christal Eshelman; Dalton Wamalwa; Agnes Langat; Ken Tapia; Helen Moraa Okinyi; Grace John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

4.  Maternal periodontitis treatment and child neurodevelopment at 24 to 28 months of age.

Authors:  Bryan S Michalowicz; James S Hodges; Richard C Lussky; Henrietta Bada; Twila Rawson; L Susan Buttross; Claudia Chiriboga; Anthony J Diangelis; M John Novak; William Buchanan; Dennis A Mitchell; Panos N Papapanou
Journal:  Pediatrics       Date:  2011-04-11       Impact factor: 7.124

5.  Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.

Authors:  Sumona Chaudhury; Paige L Williams; Gloria K Mayondi; Jean Leidner; Penny Holding; Vicki Tepper; Sharon Nichols; Jane Magetse; Maureen Sakoi; Kebaiphe Moabi; Joseph Makhema; Charlotte Mdluli; Haruna Jibril; George R Seage; Betsy Kammerer; Shahin Lockman
Journal:  Pediatrics       Date:  2017-09-14       Impact factor: 7.124

6.  Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.

Authors:  C Paula Lewis-de Los Angeles; Kathryn I Alpert; Paige L Williams; Kathleen Malee; Yanling Huo; John G Csernansky; Ram Yogev; Russell B Van Dyke; Elizabeth R Sowell; Lei Wang
Journal:  J Pediatric Infect Dis Soc       Date:  2016-12       Impact factor: 3.164

7.  Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children.

Authors:  Laurén A Gómez; Claudia S Crowell; Irene Njuguna; Lisa M Cranmer; Dalton Wamalwa; Daisy Chebet; Vincent Otieno; Elizabeth Maleche-Obimbo; Melissa Gladstone; Grace John-Stewart; Sarah Benki-Nugent
Journal:  Pediatr Infect Dis J       Date:  2018-09       Impact factor: 2.129

8.  Early antiretroviral therapy improves neurodevelopmental outcomes in infants.

Authors:  Barbara Laughton; Morna Cornell; Debbie Grove; Martin Kidd; Priscilla E Springer; Els Dobbels; Anita J van Rensburg; Avy Violari; Abdel G Babiker; Shabir A Madhi; Patrick Jean-Philippe; Diana M Gibb; Mark F Cotton
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

9.  Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Authors:  Paige L Williams; Miguel Marino; Kathleen Malee; Susan Brogly; Michael D Hughes; Lynne M Mofenson
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

10.  Neurodevelopment in Young Children Born to HIV-Infected Mothers: A Meta-analysis.

Authors:  Megan S McHenry; Carole I McAteer; Eren Oyungu; Brenna C McDonald; Chris B Bosma; Philani B Mpofu; Andrew R Deathe; Rachel C Vreeman
Journal:  Pediatrics       Date:  2018-02       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.